| Q33869877 | Activated protein synthesis and suppressed protein breakdown signaling in skeletal muscle of critically ill patients |
| Q35862009 | Comparison of Gene Expression by Sheep and Human Blood Stimulated with the TLR4 Agonists Lipopolysaccharide and Monophosphoryl Lipid A. |
| Q35842227 | Development aggravates the severity of skeletal muscle catabolism induced by endotoxemia in neonatal pigs |
| Q33655485 | Effect of a cyclooxygenase-2 inhibitor on postexercise muscle protein synthesis in humans |
| Q26996419 | Effects of prostaglandins and COX-inhibiting drugs on skeletal muscle adaptations to exercise |
| Q34697264 | Intensive care unit-acquired weakness (ICUAW) and muscle wasting in critically ill patients with severe sepsis and septic shock |
| Q27000450 | Muscle wasting in animal models of severe illness |
| Q54582240 | Novel events in the molecular regulation of muscle mass in critically ill patients. |
| Q35908213 | Plasma from septic shock patients induces loss of muscle protein. |
| Q36637854 | Prostaglandin E2/cyclooxygenase pathway in human skeletal muscle: influence of muscle fiber type and age |
| Q37666348 | Sepsis-induced myopathy |
| Q37094172 | Short-term bed rest increases TLR4 and IL-6 expression in skeletal muscle of older adults |
| Q45919849 | Survey of assessment and management of pain for critically ill adults |
| Q92784044 | TAK-242, a specific inhibitor of Toll-like receptor 4 signalling, prevents endotoxemia-induced skeletal muscle wasting in mice |
| Q36755545 | The pain, agitation, and delirium practice guidelines for adult critically ill patients: a post-publication perspective |
| Q38182345 | The skeletal muscle arachidonic acid cascade in health and inflammatory disease |
| Q62655508 | Zelluläre Regulation des Anabolismus und Katabolismus der Skelettmuskulatur bei Immobilität, im Alter und bei kritisch Kranken |